Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Sornchai Looareesuwan, MD
Woman and Man Max 99 years
Sornchai Looareesuwan, MD
Update Il y a 4 ans
Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults
This Phase II study is designed to determine whether a single 600 mg dose or 400mg/day for 3 days of tafenoquine is efficacious, and well tolerated for clearing P. vivax malaria infection ...
Country
Thailand
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sornchai Looareesuwan, MD
Update Il y a 4 ans
RBx11160 Phase II Dose Ranging Study RBx/MMV05-06
The trial will identify the best dose of the synthetic peroxide RBx11160 to treat uncomplicated malaria. Patients will be treated over 7 days with daily doses of 50, 100 or 200 mg RBx11160...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Sornchai Looareesuwan, MD
Update Il y a 4 ans
Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria
This is a double-blind, multicentre, randomised, parallel group, dose-finding study of the safety, tolerability and efficacy of a three day regimen of the combination of pyronaridine/artes...
Country
None
organs
None
Specialty
None
Closed trial
More information